EICHORCondition: Non Small Cell Lung Cancer · Lung Cancer · Sponsor: GFPC Investigation
Interested? Contact the study team ↓
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The objective of the study is to prospectively generate real-life data in patients aged ≥70 years treated in first line for a thoracic tumor (Non-Small-Cell Lung Carcinoma) according to best standard of care as defined by the European Society for Medical Oncology (ESMO). This cohort will aim to: * characterize participants in terms of geriatrics, biology and carcinology * describe the treatment modalities by stage, as well as the results in terms of efficacy, safety and impact on quality of life. At the same time, exploratory sub-cohorts will be identified including participants treated uniformly with the same molecule, and/or the same innovative strategy. Participants will be followed in accordance with investigator's usual clinical practice at the corresponding site. They will be asked to: * visit the clinic as per physician's request for checkups and tests for assessing general condition and clinical efficacy and tolerance of current treatment. * perform the necessary regular para-clinical examinations (lab testing, imaging, re-biopsy). * provide blood samples for bio-bank repository * perform assessments specific to older adults * answer three quality of life questionnaires
This description comes directly from the study's public registry record.
Romain CORRE, Medical Doctor · +330298526404 · romain.corre@ch-cornouaille.fr
Soizic FERLANDIN · +330663224789 · soizic_ferlandin@yahoo.fr
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Patient ≥70 years * Non-small-cell lung cancer for which the multidisciplinary consultation required systemic treatment regardless of Tumor-Node-Metastasis (TNM) stage * Patient naïve to systemic anticancer treatment for bronchial neoplasia * Patient covered by social security * Patient eligible for systemic treatment * Systemic treatment with marketing authorization in the indication, available in routine care early access or compassionate access. * Patient able to understand the protocol * Patient not opposed to the collection of data concerning him/her * Signature of study consent form. Exclusion Criteria: * Patients under guardians or curators * Patient not under the care of the investigating center and not monitored by the investigating center * Patient already treated with systemic therapy for NSCLC
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| CH du Pays d Aix | Aix-en-Provence, France | Recruiting |
| Hôpital Henri Duffaut | Avignon, France | Recruiting |
| Institut du Cancer d'Avignon | Avignon, France | Recruiting |
| CH Bastia | Bastia, France | Not Yet Recruiting |
| Oncologie Thoracique Hôpital Morvan | Brest, France | Recruiting |
| Pneumologie Centre François Baclesse | Caen, France | Not Yet Recruiting |
| CH Métropole-Savoie | Chambéry, France | Recruiting |
| Centre Hospitalier du Cotentin | Cherbourg, France | Recruiting |
| CHU Hôpital Montpied | Clermont-Ferrand, France | Not Yet Recruiting |
| Pneumologie Hospices Civils de Colmar | Colmar, France | Recruiting |
| Pneumologie CHI Creteil | Créteil, France | Recruiting |
| CH Elbeuf | Elbeuf, France | Recruiting |
+ 29 more locations — full list on the registry record.
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06646471